Physician profile
Samuel S Koo
NPI 1467626374
$12,851.35
in general payments reported to CMS, 2019-2025
6 companies · $19.10 in 2025
The $19.10 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,840 · 2020: $239 · 2021: $19.98 · 2022: $131 · 2023: $288 · 2024: $2,314 · 2025: $19.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,974 · Food and Beverage: $386 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,973.93 |
| Food and Beverage | $386.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $261.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $9,556.44 | 2019 | |
| Smith+Nephew, INC. | $2,177.87 | 2019-2024 | Promos, Aetos Shoulder System, Trigen Intertan |
| Djo, LLC | $642.51 | 2019-2024 | Procare |
| Zimmer Biomet Holdings, INC. | $229.90 | 2019-2023 | Comprehensive Shoulder System, Comprehensive, Medline Industries, INC. |
| Stryker Corporation | $198.52 | 2019-2024 | Aequalis Ascend Flex |
| Depuy Synthes Sales INC. | $46.11 | 2019-2025 | Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Koo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.